Intracameral Bevacizumab Versus Sub-Tenon’s Mitomycin C as Adjuncts to Trabeculectomy: 3-Year Results of a Prospective Randomized Study

Intracameral Bevacizumab Versus Sub-Tenon’s Mitomycin C as Adjuncts to Trabeculectomy: 3-Year Results of a Prospective Randomized Study

Conjunctival wound healing determines success after filtration surgery and the quest for better antifibrotic agents remains active. This study compares intracameral bevacizumab to sub-Tenon’s mitomycin C (MMC) in trabeculectomy. Primary open-angle or exfoliative glaucoma patients were randomized to...

Full description

Bibliographic Details
Main Authors: Gerasimos Kopsinis, Dimitrios Tsoukanas, Dimitra Kopsini, Theodoros Filippopoulos
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Clinical Medicine
Subjects:
trabeculectomy
bevacizumab
mitomycin C
filtration surgery
anti-fibrotic agents
wound healing
Online Access:https://www.mdpi.com/2077-0383/10/10/2054

Internet

https://www.mdpi.com/2077-0383/10/10/2054

Similar Items